Total Funding
62
65
Total FundingSeed raised
Growth Score
-3 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
59049
Cocoon brings a healthy productive life to patients worldwide initially through treatments for arthritis.
Ailis Tweed-Kent: Founder & CEO
About the Company
Cocoon Biotech’s platform technology is a biocompatible silk protein that can be injected into joints to provide effective long lasting pain relief and potentially delay the progression of disease. This platform will leverage several unique properties of the silk protein fibroin, including strength, lubrication, and biocompatibility. Their mission
is to use this technology to significantly improve the treatment of osteoarthritis and other degenerative joint disorders. The osteoarthritis treatment gap alone is currently quite large and new approaches that address both symptoms and disease progression are an urgent need.
Women Founded
Women Led
